blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1796657

EP1796657 - N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.10.2010
Database last updated on 31.08.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2009/52]
Former [2007/25]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / JAROSKOVA, Libuse, Janssen Pharmaceutica N.V.
Turnoutseweg 30
B-2340 Beerse / BE
02 / LINDERS, Joannes T.M., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
03 / VAN DER VEKEN, L.J.E., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
04 / WILLEMSENS, G.H.M., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
05 / BISCHOFF, François P., Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse / BE
 [2007/25]
Representative(s)Vervoort, Liesbeth, et al
Johnson & Johnson
Patent Law Department
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2007/25]Vervoort, Liesbeth, et al
Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date05782678.626.08.2005
[2007/25]
WO2005EP54197
Priority number, dateEP2004010415230.08.2004         Original published format: EP 04104152
US20040607851P08.09.2004         Original published format: US 607851 P
[2007/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006024627
Date:09.03.2006
Language:EN
[2006/10]
Type: A2 Application without search report 
No.:EP1796657
Date:20.06.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 09.03.2006 takes the place of the publication of the European patent application.
[2007/25]
Type: B1 Patent specification 
No.:EP1796657
Date:23.12.2009
Language:EN
[2009/52]
Search report(s)International search report - published on:EP14.02.2008
ClassificationIPC:A61K31/165, C07C235/22, C07D307/85, C07D311/66, C07D319/20, A61P3/04, A61P3/10, A61P9/00, A61P19/10, A61P25/28, A61P27/06
[2007/25]
CPC:
A61K31/165 (EP,US); C07C235/22 (EP,KR,US); A61P19/10 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P27/06 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/12 (EP); C07C237/04 (EP,US); C07C271/38 (EP,US);
C07C307/08 (EP,US); C07C311/07 (EP,US); C07C311/09 (EP,US);
C07C311/20 (EP,US); C07D207/27 (EP,US); C07D263/20 (EP,US);
C07D265/36 (EP,US); C07D295/32 (EP,US); C07D307/85 (EP,KR,US);
C07D311/66 (EP,US); C07D319/20 (EP,KR,US); C07C2603/74 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/25]
Extension statesAL14.08.2008
BA14.08.2008
HR14.08.2008
MK14.08.2008
YU14.08.2008
TitleGerman:N-2-ADAMANTANYL-2-PHENOXY-ACETAMID-DERIVATE ALS 11-BETAHYDROXYSTEROID-DEHYDROGENASE-HEMMER[2007/25]
English:N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS[2007/25]
French:DERIVES D'ACETAMIDES N-2 ADAMANTANYL-2-PHENOXY UTILISES EN TANT QU'INHIBITEURS DE LA DESHYDROGENASE 11-BETA HYDROXYSTEROIDE[2007/25]
Entry into regional phase30.03.2007National basic fee paid 
14.08.2008Designation fee(s) paid 
14.08.2008Examination fee paid 
Examination procedure14.08.2008Examination requested  [2008/40]
05.12.2008Despatch of a communication from the examining division (Time limit: M04)
17.03.2009Reply to a communication from the examining division
27.03.2009Despatch of a communication from the examining division (Time limit: M04)
27.04.2009Reply to a communication from the examining division
22.06.2009Communication of intention to grant the patent
25.09.2009Fee for grant paid
25.09.2009Fee for publishing/printing paid
Opposition(s)24.09.2010No opposition filed within time limit [2010/48]
Fees paidRenewal fee
31.08.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
31.08.2009Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.12.2009
CY23.12.2009
CZ23.12.2009
DK23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
TR23.12.2009
BG23.03.2010
GR24.03.2010
IS23.04.2010
PT23.04.2010
HU24.06.2010
LU26.08.2010
MC31.08.2010
[2012/47]
Former [2012/44]AT23.12.2009
CY23.12.2009
CZ23.12.2009
DK23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
IS23.04.2010
PT23.04.2010
HU24.06.2010
LU26.08.2010
MC31.08.2010
Former [2012/42]AT23.12.2009
CY23.12.2009
CZ23.12.2009
DK23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
IS23.04.2010
PT23.04.2010
HU24.06.2010
MC31.08.2010
Former [2011/16]AT23.12.2009
CY23.12.2009
CZ23.12.2009
DK23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
IS23.04.2010
PT23.04.2010
MC31.08.2010
Former [2011/07]AT23.12.2009
CY23.12.2009
CZ23.12.2009
DK23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
IS23.04.2010
PT23.04.2010
Former [2011/01]AT23.12.2009
CY23.12.2009
CZ23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
GR24.03.2010
IS23.04.2010
PT23.04.2010
Former [2010/40]AT23.12.2009
CZ23.12.2009
EE23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
NL23.12.2009
PL23.12.2009
RO23.12.2009
SE23.12.2009
SI23.12.2009
SK23.12.2009
BG23.03.2010
IS23.04.2010
PT23.04.2010
Former [2010/30]AT23.12.2009
FI23.12.2009
LT23.12.2009
LV23.12.2009
PL23.12.2009
SE23.12.2009
SI23.12.2009
Former [2010/25]FI23.12.2009
LT23.12.2009
LV23.12.2009
PL23.12.2009
SE23.12.2009
SI23.12.2009
Former [2010/24]FI23.12.2009
LT23.12.2009
PL23.12.2009
SE23.12.2009
SI23.12.2009
Former [2010/21]LT23.12.2009
SE23.12.2009
Cited inInternational search[A]WO9604254  (FUJISAWA PHARMACEUTICAL CO [JP], et al) [A] 1-19 * abstract *;
 [A]WO9926927  (NPS PHARMA INC [US], et al) [A] 1-19 * abstract * * page 29, lines 19-125; figure 1; claims 18,19 *;
 [AD]WO0123399  (PFIZER PROD INC [US], et al) [AD] 1-19 * abstract *;
 [A]EP1127883  (HOFFMANN LA ROCHE [CH]) [A] 1-19 * abstract * * page 108, line 10 *;
 [A]WO2004056744  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-19 * the whole document *;
 [XP]WO2004089470  (NOVO NORDISK AS [DK], et al) [XP] 1-5,7,9,10,14-19 * abstract * * page 29, line 2 * * page 36, line 3 * * page 76, line 33 - page 79, line 2; claim 15 *;
 [XP]WO2004089415  (NOVO NORDISK AS [DK], et al) [XP] 1-5,7,9,10,14-19 * abstract * * page 3, lines 9-14 * * page 54, line 33 * * page 62, line 3 * * page 159, line 33 - page 162, line 2 * * page 220, line 25; claim 8 *;
 [XP]WO2004089416  (NOVO NORDISK AS [DK], et al) [XP] 1-5,7,9,10,14-19 * abstract * * page 3, lines 11-17 * * page 60, line 1 * * page 153, line 34 - page 156, line 3 * * page 212, line 35; claim 8 *;
 [X]  - CHEMCATS, (20031020), XP002354668 [X] 5,9,10 * column A *
 [A]  - CHEMCATS, (20030423), Database accession no. 2001:711911, XP002316807 [A] 1-19 * column A; compounds RN 332399-46-9 *
 [A]  - CHEMCATS, (20030811), Database accession no. 2001:1353682, XP002316808 [A] 1-19 * column A; compounds RN 339060-39-8 *
 [A]  - CHEMCATS, (20030425), Database accession no. 2001:2280339, XP002316809 [A] 1-19 * column A; compounds RN 339060-39-8 *
 [A]  - CHEMCATS, (20031020), Database accession no. 2002:1350205, XP002316810 [A] 1-19 * column A; compounds RN 405076-63-3 *
 [A]  - CHEMCATS, (20031020), Database accession no. 2002:1350218, XP002316811 [A] 1-19 * column A; compounds RN 405076-76-8 *
 [A]  - SABRI S S ET AL, "Syntheses and Antibacterial Activity of Some New N-(3-Methyl-2-quinoxalyl) Amino Alcohols and Amine 1,4-Dioxides", JOURNAL OF CHEMICAL AND ENGINEERING DATA, AMERICAN CHEMICAL SOCIETY, US, (1984), vol. 29, no. 2, ISSN 0021-9568, pages 229 - 231, XP002101982 [A] 1-19 * abstract *

DOI:   http://dx.doi.org/10.1021/je00036a039
 [A]  - AVDYUNINA, N. I. ET AL, "N-Adamantylamides of benzimidazoline-3-acetic acids: synthesis and pharmacological properties", KHIMIKO-FARMATSEVTICHESKII ZHURNAL , 22(7), 819-22 CODEN: KHFZAN; ISSN: 0023-1134, (1988), XP008042581 [A] 1-19 * the whole document *
by applicantWO2004089416
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.